Newbridge Financial Services Group, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $262 Million
- Q2 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 2,340 shares of RXRX stock, worth $16,614. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,340
Previous 2,340
-0.0%
Holding current value
$16,614
Previous $23,000
26.09%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
291Shares Held
239MCall Options Held
984KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$233 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$179 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$153 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$123 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$109 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.28B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...